virus del papiloma humano y cáncer: epidemiología y prevención ...
virus del papiloma humano y cáncer: epidemiología y prevención ...
virus del papiloma humano y cáncer: epidemiología y prevención ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
F. Xavier Bosch José, Mireia Diaz Sanchis, Silvia de Sanjosé Llongueras, Rebeca Font Marimon,<br />
Xavier Castellsagué Piqué, Ginesa Albero Abril, Belén Lloveras Rubio, Joellen Klaustermeier Lloveras,<br />
Víctor Moreno Aguado.<br />
tico. Este artículo ha sido parcialmente financiado en España por ayudas <strong>del</strong><br />
Instituto de Salud Carlos III (FIS 03-0240, RCESP C03/09 y RTICCC C03/10 y<br />
de la Comisión Europea (QLG4-CT-2000-01238 y QLG4-CT-2001-30142).<br />
2.12. Bibliografía<br />
1. De Sanjosé S, Díaz M, Castellsagué X, Clifford G, Muñoz N, Bosch FX.<br />
Worldwide prevalence and genotype distribution of cervical HPV DNA in<br />
169-341 women from general population. A meta-analysis of the international<br />
literature; 2006 (enviado para publicación).<br />
2. Bosch FX, Lorincz A, Muñoz N, Meijer CJLM, Shah KV. The causal relation<br />
between human papilloma<strong>virus</strong> and cervical cancer. J Clin Pathol.<br />
2002; 55(4): 244-65.<br />
3. Bosch FX, de Sanjosé S. Chapter 1: human papilloma<strong>virus</strong> and cervical<br />
cancer-burden and assessment of causality. J Natl Cancer Inst Monogr.<br />
2003; (31): 3-13.<br />
4. Muñoz N, Méndez F, Posso H, Molano M, van Den Brule AJ, Ronderos<br />
M y cols. Incidence, duration, and determinants of cervical human<br />
papilloma<strong>virus</strong> infection in a cohort of Colombian women with normal<br />
cytollogical results. J Infect Dis. 2004; 190(12): 2077-87.<br />
5. Khan MJ, Castle PE, Lorincz AT, Wacholder S, Sherman M, Scott DR y cols.<br />
The elevated 10-year risk of cervical precancer and cancer in women<br />
with human papilloma<strong>virus</strong> (HPV) type 16 or 18 and the possible utility<br />
of type-specific HPV testing in clinical practice. J Natl Cancer Inst. 2005;<br />
97(14): 1072-9.<br />
6. Castle PE, Solomon D, Schiffman M, Wheeler CM. Human papilloma<strong>virus</strong><br />
type 16 infections and 2-year absolute risk of cervical precancer<br />
in women with equivocal or mild cytologic abnormalities. J Natl Cancer<br />
Inst. 2005; 97(14): 1066-71.<br />
7. Moreno V, González JR, Soler M, Bosch FX, Kogevinas M, Borràs JM.<br />
Estimación de la incidencia de <strong>cáncer</strong> en España: período 1993-1996.<br />
Gac Sanit. 2001; 15(5): 380-8.<br />
8. Vizcaíno AP, Moreno V, Bosch FX, Muñoz N, Barros-Dios XM, Parkin<br />
DM. International trends in the incidence of cervical cancer: I.<br />
Adenocarcinoma and adenosquamous cell carcinomas. Int J Cancer.<br />
1998; 75: 536-45.<br />
9. Bulk S, Visser O, Rozendaal L, Verheijen RH, Meijer CJ. Cervical cancer<br />
in the Netherlands 1989-1998: Decrease of squamous cell carcinoma in<br />
older women, increase of adenocarcinoma in younger women. Int J<br />
Cancer. 2005; 113(6): 1005-9.<br />
48
Change language